Helper-dependent adenoviruses show great promise as gene delivery vectors.
However, because they do not integrate into the host chromosome, transgene
expression cannot be maintained indefinitely. To overcome these limitations
, we have inserted an L1 retrotransposon/transgene element into a helper-de
pendent adenovirus to create a novel chimeric gene delivery vector. Efficie
nt adenovirus-mediated delivery of the L1 element into cultured human cells
results in subsequent retrotransposition and stable integration of the tra
nsgene. L1 retrotransposition frequency was found to correlate with increas
ing multiplicity of infection by the chimeric vector, and further retrotran
sposition from newly integrated elements was not observed on prolonged cult
ure. Therefore, this vector, which utilizes components of low immunogenic p
otential, represents a novel two-stage gene delivery system capable of achi
eving high titers via the initial helper-dependent adenovirus stage and per
manent transgene integration via the retrotransposition stage.